thymine has been researched along with Cancer of Ovary in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y | 1 |
Wang, DD | 1 |
Wu, YP | 1 |
Su, D | 1 |
Zhou, TY | 1 |
Gai, RH | 1 |
Fu, YY | 1 |
Zheng, L | 1 |
He, QJ | 1 |
Zhu, H | 1 |
Yang, B | 1 |
Roy, J | 1 |
Kaake, M | 1 |
Srinivasarao, M | 1 |
Low, PS | 1 |
Vortel, V | 1 |
Peychl, L | 1 |
Wolberg, WH | 1 |
Skoda, V | 2 |
Elis, J | 2 |
Jandová, A | 2 |
Laurová, L | 1 |
Novotná, J | 1 |
Perlík, F | 2 |
Dvorák, O | 1 |
Kvícalová, M | 1 |
Kafka, V | 1 |
1 trial available for thymine and Cancer of Ovary
Article | Year |
---|---|
A controlled clinical trial with the cytostatic agent thyminalkylamine and its fluorinated derivative on advanced ovarian tumours.
Topics: Alkylating Agents; Female; Fluorine; Hemodynamics; Humans; Leukocyte Count; Leukocytes; Lung Neoplas | 1971 |
5 other studies available for thymine and Cancer of Ovary
Article | Year |
---|---|
MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
Topics: Aminoquinolines; Antigens, CD; Blotting, Western; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movem | 2017 |
Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Endometrial Neoplasms; Fema | 2018 |
[2 cases of acquired latent focal toxoplasmosis of the brain in a cytostatic and corticosteroid treated neoplastic disease].
Topics: Autopsy; Brain; Brain Diseases; Busulfan; Female; Focal Infection; Glycine; Humans; Leukemia, Myeloi | 1970 |
Response of DNA thymine synthesis in human tumor and normal tissue to 5-fluorouracil.
Topics: Breast Neoplasms; Carbon Isotopes; Chromatography, Paper; Colon; Colonic Neoplasms; Depression, Chem | 1972 |
Comparison of effects of cyclophosphamide, Cytembena, and Ypenyl in the treatment of inoperable ovarian carcinoma.
Topics: Acrylates; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Bromine; Cyclophosph | 1971 |